CEO: Fredrik Ullman
Head office: Zürich, Switzerland
Employees: 55
Acquisition year: 2018
Industry: Diagnostics
Website: indical.com
Diagnostic solutions provider for veterinary specific applications
Diagnostic solutions provider for veterinary specific applications
Indical Bioscience is a leading provider of diagnostic products specifically developed for veterinary specific applications.
The company develops and markets diagnostic solutions and products based on PCR (molecular) and ELISA (immunodiagnostic) technology. The products are used by laboratories primarily to indicate and diagnose viruses and bacteria in production animals, to counteract proliferation and contribute to better animal and human health. Indical Bioscience is based in Germany and serves customers in 169 countries through its own sales force and commercial partners.
CEO: Fredrik Ullman
Head office: Zürich, Switzerland
Employees: 55
Acquisition year: 2018
Industry: Diagnostics
Website: indical.com
Indical has acquired Afosa GmbH, a leading provider of ELISA diagnostics products to the companion animal sector, based in Germany. Indical has a strong diagnostics portfolio focused on production animals, which is built on more than twenty years of research
Read moreBiomeme and Indical enters into an exclusive global licensing and research agreement in a joint effort to improve animal health globally. Biomeme has developed an advanced mobile PCR detection technology that solves time-sensitive and location-sensitive problems where results need to
Read moreFidelio acquires Indical Bioscience, a leading provider of diagnostic products specifically developed for veterinary specific applications. The company develops and markets diagnostic solutions and products based on PCR (molecular) and ELISA (immunodiagnostic) technology. The products are used by laboratories primarily
Read more